BEIJING, July 7 /PRNewswire-Asia-FirstCall/ — Lotus
Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (“Lotus” or the
“Company”), a growing developer, manufacturer and seller of
medicine and drugs in the People’s
Republic of China (the “PRC”), today announced it will
present at the Global Hunter Securities 2010 China Conference held
July 11-13, 2010 in San Francisco, California. Presentation
details are noted below.
Date: Monday, July 12, 2010
Time: 3:30 PM
Location: The St. Regis Hotel, San Francisco, CA
Lotus will also be available for one-on-one meetings with
investors on the 12th and 13th. Investors interested in attending
the event should contact Global Hunter Securities. For more
information about the conference, please visit http://www.ghsecurities.com/
.
About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com
)
Lotus Pharmaceuticals, Inc. is a growing developer and producer
of drugs and a licensed national seller of pharmaceutical items in
the PRC. Lotus operates its business through its two controlled
entities: Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi
Pharmaceutical, Ltd. Lotus’ current drug development is focused on
the treatment of cerebro-cardiovascular disease, asthma, and
dia
‘/>”/>
